The association between serum lipid profile and the prostate cancer risk and aggressiveness
暂无分享,去创建一个
Choung-Soo Kim | I. Jeong | D. You | H. Ahn | J. Suh | J. Hong | T. J. Shin
[1] Julio M. Pow‐Sang,et al. Management of Patients With Nonmetastatic Prostate Cancer , 2022, Journal of the National Comprehensive Cancer Network.
[2] A. Jemal,et al. Cancer statistics, 2022 , 2022, CA: a cancer journal for clinicians.
[3] Natalia Scaglia,et al. Prostate Cancer Progression: as a Matter of Fats , 2021, Frontiers in Oncology.
[4] G. Norata,et al. Global epidemiology of dyslipidaemias , 2021, Nature Reviews Cardiology.
[5] G. Lee,et al. Associations of Serum Lipid Level with Gastric Cancer Risk, Pathology, and Prognosis , 2020, Cancer research and treatment : official journal of Korean Cancer Association.
[6] Jacob D. Jaffe,et al. High-fat diet fuels prostate cancer progression by rewiring the metabolome and amplifying the MYC program , 2019, Nature Communications.
[7] M. Loda,et al. Inhibition of de novo lipogenesis targets androgen receptor signaling in castration-resistant prostate cancer , 2018, Proceedings of the National Academy of Sciences.
[8] S. Egawa,et al. Epidemiology of prostate cancer in Asian countries , 2018, International journal of urology : official journal of the Japanese Urological Association.
[9] S. Serni,et al. Meta-analysis of metabolic syndrome and prostate cancer , 2017, Prostate Cancer and Prostatic Diseases.
[10] M. Wirth,et al. Increasing use of radical prostatectomy for locally advanced prostate cancer in the USA and Germany: a comparative population-based study , 2016, Prostate Cancer and Prostatic Diseases.
[11] L. Butler,et al. Androgen control of lipid metabolism in prostate cancer: novel insights and future applications. , 2016, Endocrine-related cancer.
[12] H. Brenner,et al. Blood lipids and prostate cancer: a Mendelian randomization analysis , 2016, Cancer medicine.
[13] Mats Lambe,et al. Association between baseline serum glucose, triglycerides and total cholesterol, and prostate cancer risk categories , 2016, Cancer medicine.
[14] Choung-Soo Kim,et al. Epidemiology of prostate cancer in South Korea , 2015, Prostate international.
[15] L. Pengfei,et al. Cholesterol Levels in Blood and the Risk of Prostate Cancer: A Meta-analysis of 14 Prospective Studies , 2015, Cancer Epidemiology, Biomarkers & Prevention.
[16] M. Terris,et al. Serum Lipid Profile and Risk of Prostate Cancer Recurrence: Results from the SEARCH Database , 2014, Cancer Epidemiology, Biomarkers & Prevention.
[17] A. Kural,et al. Prostate cancer in Asia: A collaborative report , 2014, Asian journal of urology.
[18] Yong Q. Chen,et al. Lipids and prostate cancer. , 2012, Prostaglandins & other lipid mediators.
[19] Edward Giovannucci,et al. The correlation between metabolic syndrome and prostatic diseases. , 2012, European urology.
[20] L. Holmberg,et al. Prostate cancer risk in the Swedish AMORIS study , 2011, Cancer.
[21] Stephen L. Abrams,et al. Roles of the Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR pathways in controlling growth and sensitivity to therapy-implications for cancer and aging , 2011, Aging.
[22] J. Klenk,et al. Serum triglyceride concentrations and cancer risk in a large cohort study in Austria , 2009, British Journal of Cancer.
[23] K. Nakajima,et al. Remnant lipoproteins induced proliferation of human prostate cancer cell, PC-3 but not LNCaP, via low density lipoprotein receptor. , 2009, Cancer epidemiology.
[24] Shou-En Lu,et al. Cancer incidence among Korean-American immigrants in the United States and native Koreans in South Korea. , 2007, Cancer control : journal of the Moffitt Cancer Center.
[25] Jayoung Kim,et al. Cholesterol targeting alters lipid raft composition and cell survival in prostate cancer cells and xenografts. , 2005, The Journal of clinical investigation.
[26] T. Hansen,et al. A common polymorphism in the promoter of the IGF-I gene associates with increased fasting serum triglyceride levels in glucose-tolerant subjects. , 2004, Clinical biochemistry.
[27] M. Loda,et al. The isopeptidase USP2a regulates the stability of fatty acid synthase in prostate cancer. , 2004, Cancer cell.
[28] R. Vessella,et al. Increased AKT Activity Contributes to Prostate Cancer Progression by Dramatically Accelerating Prostate Tumor Growth and Diminishing p27Kip1 Expression* , 2000, The Journal of Biological Chemistry.
[29] P. Malone,et al. Prostate , 1995 .
[30] G. Mcclearn,et al. Genetic and environmental influences on serum lipid levels in twins. , 1993, The New England journal of medicine.